计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C130177-5mg |
5mg |
现货 ![]() |
| |
C130177-10mg |
10mg |
现货 ![]() |
| |
C130177-25mg |
25mg |
现货 ![]() |
|
别名 | 27-羟基胆固醇 | 25(R)-27-羟基胆固醇 | (25R)-26-羟基胆固醇 | (25R)-胆甾-5-烯-3b | 26-二醇 | 27-羟基胆固醇(25R) | 胆甾-5-ene-3β,27-二醇 | 11081825(R)-27-羟基胆固醇 |
---|---|
英文别名 | 27-OHC | (25R) | 110818 | Cholest-5-ene-3-b,27-diol | PD018880 | CHOLEST-5-ENE-3.BETA.,26-DIOL, (25R)- | EX-A7666 | (25R)-26-Hydroxycholesterol | 26-HYDROXYCHOLESTEROL, (25R)- | Cholest-5-ene-3-beta,27-diol | Cholest-5-ene-3beta,27-diol | LMST01010088 | C |
规格或纯度 | Moligand™, ≥99% |
英文名称 | cholest-(25R)-5-ene-3β,27-diol |
生化机理 | LXR激动剂。雌激素受体部分激动剂。\ xa0调节乳腺癌细胞系中的基因表达。 |
应用 | An oxysterol with cholesterol oxidation metabolite properties. |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
作用类型 | 激动剂 |
作用机制 | GPR183 激动剂;肝 X 受体-α 激动剂;肝 X 受体-β 激动剂 |
备注 | 有关更多信息,请参阅SDS。有关溶解度,用法和处理的更多建议?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
27-羟基胆固醇(27-HC)是由胆固醇在肝脏中的甾醇27-羟化酶作用下合成的。在0.15至0.73 μM的循环范围中,它是一种丰富的氧化甾醇。27-HC是胆汁合成的底物 应用: 观察其对肝脏脂质积累的抑制作用;作为乳腺癌细胞系中的肝X受体(LXR)配体;作为液相色谱-串联质谱(LC-MS-MS)法中的对照,量化空肠样品中的25-OHC
27-hydroxycholesterol (27-HC) is synthesized by cholesterol under the action of sterol 27-hydroxylase in the liver. It is an abundant oxidizing sterol in the cyclic range of 0.15 to 0.73 μM. 27-HC is a substrate for bile synthesis
Product description: 27-Hydroxycholesterol, an oxysterol secreted from macrophages, has been shown to be capable of passing through the blood-brain barrier and entering the circulation via the brain. This compound has been shown to be a cholesterol oxidation metabolite that causes an increase in levels of GADD 153 and caspase-12 in ARPE-19 cells in vitro. 27-Hydroxycholesterol has also been reported to increase levels of Aβ peptide production, reduce mitochondrial membrane potential, and induce nuclear factor κB (NFκB) and heme-oxygenase 1 (HO-1). Overall, 27-Hydroxycholesterol displays apoptotic properties via reactive oxygen species (ROS) generation, glutathione depletion, and inflammation. 27-Hydroxycholesterol is an activator of LXR α and LXR β. Application:
To observe its inhibitory effect on lipid accumulation in liver. As a liver X receptor (LXR) ligand in breast cancer cell lines; As a control in liquid chromatography-tandem mass spectrometry (LC-MS-MS), 25-OHC in jejunum samples was quantified
|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504756957 |
---|---|
分子类型 | 小分子 |
IUPAC Name | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
INCHI | InChI=1S/C27H46O2/c1-18(17-28)6-5-7-19(2)23-10-11-24-22-9-8-20-16-21(29)12-14-26(20,3)25(22)13-15-27(23,24)4/h8,18-19,21-25,28-29H,5-7,9-17H2,1-4H3/t18-,19-,21+,22+,23-,24+,25+,26+,27-/m1/s1 |
InChi Key | FYHRJWMENCALJY-YSQMORBQSA-N |
Canonical SMILES | CC(CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO |
Isomeric SMILES | C[C@H](CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)CO |
PubChem CID | 123976 |
分子量 | 402.65 |
溶解性 | ≤20mg/ml in ethanol;0.1mg/ml in DMSO;2mg/ml in dimethyl formamide |
---|---|
分子量 | 402.700 g/mol |
XLogP3 | 7.100 |
氢键供体数Hydrogen Bond Donor Count | 2 |
氢键受体数Hydrogen Bond Acceptor Count | 2 |
可旋转键计数Rotatable Bond Count | 6 |
精确质量Exact Mass | 402.35 Da |
单同位素质量Monoisotopic Mass | 402.35 Da |
拓扑极表面积Topological Polar Surface Area | 40.500 Ų |
重原子数Heavy Atom Count | 29 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 612.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 9 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine
A comparison of N-palmitoyl ceramide phosphoserine with dipalmitoyl phosphatidylserine